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ABSTRACT
The S phase checkpoint is crucial to maintain
genome stability under conditions that threaten DNA
replication. One of its critical functions is to pre-
vent Exo1-dependent fork degradation, and Exo1 is
phosphorylated in response to different genotoxic
agents. Exo1 seemed to be regulated by several
post-translational modifications in the presence of
replicative stress, but the specific contribution of
checkpoint-dependent phosphorylation to Exo1 con-
trol and fork stability is not clear. We show here
that Exo1 phosphorylation is Dun1-independent and
Rad53-dependent in response to DNA damage or
dNTP depletion, and in both situations Exo1 is sim-
ilarly phosphorylated at multiple sites. To investi-
gate the correlation between Exo1 phosphorylation
and fork stability, we have generated phospho-mimic
exo1 alleles that rescue fork collapse in rad53 mu-
tants as efficiently as exo1-nuclease dead mutants or
the absence of Exo1, arguing that Rad53-dependent
phosphorylation is the mayor requirement to pre-
serve fork stability. We have also shown that this
rescue is Bmh1–2 independent, arguing that the 14-
3-3 proteins are dispensable for fork stabilization,
at least when Exo1 is downregulated. Importantly,
our results indicated that phosphorylation specifi-
cally inhibits the 5’ to 3’exo-nuclease activity, sug-
gesting that this activity of Exo1 and not the flap-
endonuclease, is the enzymatic activity responsible
of the collapse of stalled replication forks in check-
point mutants.
INTRODUCTION
Conditions that perturb DNA replication are an important
threat to genomic stability. The ability to overcome them
depends on the S phase checkpoint, which is a surveillance
mechanism that responds to replication perturbations and
coordinates a global response to ensure successful chromo-
some replication and to preserve genome integrity and cell
survival (1,2).
Commonly, cancer cells present a defective checkpoint
pathway (3), which render these cells sensitive to chemother-
apeutic agents that inhibit DNA replication. Therefore, it is
important to understand the cellular mechanisms that sense
and respond to replication perturbations to improve the effi-
ciency of anti-cancer therapies. In addition, replication fork
blockage is linked to the appearance of chromosomal rear-
rangements and breakage, which are an important source of
genome instability (4) and it is well established that check-
point pathways contribute to maintain genomic stability (5–
7) and represent a barrier to carcinogenesis too (8,9).
The S phase checkpoint involves Mec1 and Rad53 ki-
nases in Saccharomyces cerevisiae (2), corresponding to
ATR and CHK1 in human cells (10–12), and to Rad3 and
Cds1 in Schizosaccharomyces pombe (13,14). In conditions
that threaten DNA replication, such as DNA damage or
nucleotide depletion, the S phase checkpoint gets activated
with the kinase Mec1 being recruited to stalled replication
forks and the subsequent phosphorylation of the effector ki-
nase Rad53 and the downstream kinase Dun1 (15,16). The
checkpoint response regulates different processes such as in-
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hibition of mitosis, transcription of ribonucleotide reduc-
tase (RNR) and other genes involved in the DNA damage
response (DDR) and inhibition of late origin firing (17–21).
All of these processes contribute to cell survival, but it seems
that preserving replication fork stability is critical (22). The
S phase checkpoint preserves the integrity and functional-
ity of DNA replication forks to ensure full chromosome
replication after replication perturbations have been solved
(23,24). In the absence of a functional checkpoint, replica-
tion forks are irreversibly damaged, a state known as fork
collapse.
The nature of fork collapse in checkpoint mutants treated
with the RNR inhibitor hydroxyurea (HU) is not well un-
derstood, but it is characterized by the presence of ab-
normal DNA structures, which have not been observed
in wild-type cells. In particular, the collapse of stalled
replication forks leads to a reduced percentage of DNA
replication bubbles analysed by two-dimensional (2D) gel
electrophoresis, together with an accumulation of unusual
DNA replication intermediates at forks. These aberrant
structures observed by electron-microscopy (EM) include
a high proportion of stalled replication bubbles with long
stretches of single-stranded DNA (ssDNA), and a smaller
amount of forks with gaps and reversed forks (24–26).
The origin of these unusual structures is not clear, al-
though different factors could contribute to their forma-
tion. One possibility is that, in the absence of a functional
checkpoint, inappropriate exposure of replication interme-
diates at stalled forks may lead to degradation of the strands
and the accumulation of ssDNA regions. This would be
caused by replisome disassembling in checkpoint mutants
(27–29), although it has been recently shown that the repli-
some remains stably associated with stalled forks in yeast
and human cells (30,31); other possible scenario is the im-
proper unwinding of the newly synthesized strands (32),
or other unrevealed events. In any case, these abnormal
DNA transitions would expose newly synthesized DNA to
nucleolytic processing, leading to irreversible fork collapse
(23,24).
One nuclease implicated in fork degradation is Exo1, a
Rad2 family nuclease with a double strand-specific 5´ to
3´exonuclease and 5´flap endonuclease activities involved
in different cellular processes and repair pathways, like
Okazaki fragment maturation, telomere processing, mis-
match repair, double-strand break (DSB) repair, and mi-
totic and meiotic recombination (33–40).
Fork collapse of rad53 mutants exposed to HU or DNA
damaging agents is dependent on the presence of Exo1,
and thus, EXO1 deletion preserves the stability of replica-
tion forks in rad53 mutants in the presence of both HU
and methyl methanesulphonate (MMS) (29,41). However,
the requirements to maintain functional replication forks
and survive to replication blockage seem to be different af-
ter exposure to MMS or HU. Thus, elimination of EXO1
suppresses the defect in fork progression of rad53 mu-
tant cells in the presence of the DNA alkylating agent
MMS and notably increases viability (41,42), while addi-
tional Exo1-independent mechanisms are required to per-
mit replication-fork restart and viability after HU treatment
(41). This additional mechanism depends, at least in part,
on the Rad53-dependent induction of RNR2, RNR3 and
RNR4 genes (17), as RNR2–3-4 expression in the absence
of Exo1 promotes replication resumption after fork stalling
in rad53 mutants and improves resistance to HU (43). New
synthesis and activation of the RNR enzymatic complex
might be especially important after a prolonged treatment
with the inhibitor HU.
It has been proposed that Exo1 resects stalled and re-
versed forks in rad53 cells treated with HU (44), and also
that the nuclease activity of Exo1, together with Dna2 and
Sae2, would counteract the generation of some of these
abnormal replication intermediates, like the reversed forks
(45). Thus, it is currently unclear whether these DNA struc-
tures are substrates or products of Exo1 activity, and the
biochemical Exo1 activity responsible of fork degradation
has not been determined yet.
In budding yeast, Exo1 is phosphorylated in vivo af-
ter DNA damage or telomeric stress by checkpoint ki-
nases (46–49), and in human cells after fork stalling, EXO1
is also phosphorylated by the checkpoint machinery. In
this case, ATR-dependent phosphorylation of Exo1 leads
to ubiquitin-mediated degradation of the protein (50,51),
whereas in yeast this regulatory mechanism has not been
observed. In addition, human EXO1 undergoes CDK-
dependent phosphorylation in S- and G2-phase, which
modulates its recruitment to DNA during DSB resection
(52). Mec1-dependent phosphorylation of yeast Exo1 was
proposed to limit Exo1 activity at uncapped telomeres (47);
but the biological consequences of this phosphorylation
and, in particular, how could influence fork stability have
not been clarified. In addition to phosphorylation, it has
been recently reported that both yeast and human EXO1
are also SUMOylated in response to DNA replication
stress (53), and proposed that sumoylation regulates human
EXO1 stability and ubiquitin-mediated EXO1 degradation.
Also, it has been shown that Exo1 in vivo interacts with
14-3-3 proteins, both in yeast and mammalian cells (48).
In yeast, this interaction is HU-dependent and it has been
suggested that it modulates the phosphorylation of Exo1,
which would limit its activity and, therefore, would influ-
ence fork stability and progression in response to DNA
replication stress (48).
Despite all this information about EXO1 control in dif-
ferent conditions and systems, how checkpoint-dependent
Exo1 regulation protects replication forks is not under-
stood.
Here we have shown that Exo1 phosphorylation oc-
curs with a similar pattern in response to MMS or HU
treatment, and in both situations specifically depends on
the checkpoint kinase Rad53. We have generated exo1-
phosphomimic alleles that rescue fork collapse in rad53 mu-
tants in HU independently of the 14-3-3 proteins, argu-
ing that Rad53-dependent phosphorylation of Exo1 is suf-
ficient to restrain its deleterious action at stalled replica-
tion forks. Importantly, our results indicated that the phos-
phomimic Exo1–23D variant is deficient specifically in 5′-
3′exonuclease activity, arguing that phosphorylation has a
direct inhibitory effect on this catalytic activity of Exo1. In
fact, both in vivo and in vitro data suggest that Exo1 flap-
activity is not primarily involved in fork degradation and,
points at the 5′-3′exonuclease activity as responsible of the
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MATERIALS AND METHODS
Strains and grow conditions
All yeast strains used in this work derive from W303 and are
described in the Supplementary Table S1. Phospho-mutants
exo1–23D and exo1–23A were constructed by delitto per-
fetto (54) using artificially synthesized genes made by Ge-
neWiz carrying the modifications detailed in the Supple-
mentary Table S2. The exo1-D173A and exo1-E150D al-
leles from YIp-exo1-D173A and YIp-exo1-E150D respec-
tively (55) were used to replace the wild-type EXO1 frag-
ment by delitto perfetto (54). All the exo1-mutant strains
were sequenced to verify correct replacement with the mu-
tated fragments. The rest of the strains were constructed us-
ing standard techniques.
Cells were grown in YPD medium at 30◦C and synchro-
nized in G1 phase using the mating pheromone -factor at
10 g/ml. Then cells were released into S phase in medium
with either 0.033% MMS or 0.2M HU.
For synthetic lethality analysis, a rad27Δ mutant strain
was crossed with different exo1 mutants of the opposite
mating type to generate diploids that were tetrad dissected
after sporulation to analyse the viability of the progeny.
Drop assay
Cell cultures were grown overnight until they reach the sta-
tionary phase and then 1:5 serial dilutions were spotted into
YPD or YPD with HU or different concentrations of MMS,
depending on the experiment. Lastly, plates were incubated
at 30◦C for 3 days.
Flow cytometry
108 cells were fixed in 70% ethanol after sample collection
and then washed in 50 mM sodium citrate prior flow cy-
tometry analysis. After the wash, cells were first treated
with RNase A (0.1 mg/ml) and then with Proteinase K (0.8
mg/ml). Finally, cells were washed in 50 mM sodium cit-
rate again and resuspended in 50 mM sodium citrate with
4 g/ml of propidium iodide. Treated cells were then anal-
ysed in a Facscalibur flow cytometer (BD biosciences).
Protein electrophoresis, immunoblotting and immunoprecipi-
tation
Protein extracts and electrophoretic conditions were per-
formed as described (43). When specified, Phos-tag™
reagent (Wako chemicals, AAL-107) and MnCl2 were
added to 7.5% sodium dodecyl sulphate-polyacrylamide
gelelectrophoresis (SDS-PAGE) gels to a final concentra-
tion of 5 mM and 160 nM, respectively. Proteins were sep-
arated at constant amperage of 30 mA per gel in a Mini-
protean III (Bio-Rad) or at 60 mA per gel in a TV200 (Scie-
Plas), both for 90 min. After the electrophoresis, the gel
was incubated in standard transfer buffer with ethylenedi-
aminetetraacetic acid (EDTA) at 0.1M for 30 min, followed
by three washes with transfer buffer for 10 min. Then, the
gel was transferred to a PVDF membrane (Immobilon-P,
Millipore) in a Mini-Transfer system (Bio-Rad) at 200 mA
overnight. Exo1-MYC was detected using the mouse mon-
oclonal -MYC antibody clone 4A6 (Millipore; dilution
1:1000). Detection of Rad53 was performed using a rabbit
polyclonal antibody provided by J. Diffley (JDI48; dilution
1:1000) and PGK was detected using the mouse polyclonal
antibody 22C5 (Sigma; dilution 1:20 000). The correspond-
ing protein A or -mouse secondary antibody coupled with
horseradish peroxidase were used at 1:5000 dilution, and fi-
nally immunoreactive bands were visualized by enhanced
chemiluminescence (ECL, GE Healthcare). Alternatively,
goat -mouse secondary antibodies coupled to Alexa Fluor
Plus 800 (Thermo, dilution 1:5000) were employed for pro-
tein detection on an Odyssey scanner (Li-Cor Biosciences).
Immunoprecipitations were performed as described (56).
PhosSTOP phosphatase inhibitors (Roche) were added in
lysis and washing buffers as indicated by the manufacterer.
Exo1-MYC was pulled down with 10 g of -MYC anti-
body (Millipore, clone 4A6) and 15 l of Protein G loaded
Dynabeads (Invitrogen), and Bmh1-PK was detected by
immunoblot with the mouse -V5-TAG antibody (AbD
Serotec dilution 1:20 000).
Nuclease activity assays
Protein extracts were made as for co-immunoprecipitations
(56) but the lysis buffer was supplemented with 200 mM
potassium acetate. To measure nuclease activity, MYC-
tagged Exo1 variants were immunoaffinity purified with
-MYC antibody (9E10, Cancer Research UK) coupled to
agarose beads with the AminoLink kit (Thermo Scientific,
44894). A total of 20 l 50% bead slurry and 500 l cell ex-
tracts were mixed for 30 min at 4◦C and washed twice with
lysis buffer containing 200 mM potassium acetate and twice
with lysis buffer containing 500 mM potassium acetate.
The beads were then equilibrated in 1 ml reaction buffer
(25 mM Tris–HCl pH 8.0, 75 mM NaCl, 1 mM DTT, 10
mM MgCl2, 4% glycerol) and split for western blot analysis
(20%) and nuclease assays (80%). Synthetic DNA substrates
were prepared as described (57), employing the following
oligonucleotides: (i) splayed arm, 5´FAM-A6 (5′-6FAM-
A*T*T*GGTTA TTTACCGAGCTCGAATTCACTGG-
3′, with asterisks indicating phosphorothioate linkages)
+ A9 (5′-CCAGTGAATTCGAGCTCGGTACCCGC
TAGCGGGGATC CTCTA-3´); (ii) 5′-recessed ds-
DNA, A6–3´FAM (5′-ATTGGTTATTTACCGAGCT
CGAATTCACTGG-6FAM-3′) + A6-comp-poliT (5′-
CCAGTGAATTCGAGCT CGGTAAATAACCAA
TTTTTT-3′); (iii) dsDNA, X01 (5′-ACGCTGCCGAA
TTCTACCAGTGCCTTGCTAGGACATCTTTGCCCA
CCTGCAGGTTCACCC-3′) + X01-comp (5′- GGGT
GAACCTGCAGGTGGGCAAAGATGTCCTAGCAA
GGCACTGGTAGAATTCGGCAGCGT-3′); (iv) ss-
DNA, X0–1. Beads for nuclease assays were resuspended
in 5 l 2× reaction buffer and 5 l DNA mix (20 nM fluo-
rescently labelled substrate, with 10 nM competitor ssDNA
and 10 nM competitor dsDNA) and incubated for 10 min
at 30◦C with gentle agitation. For analysis of exonuclease
activity, reactions were stopped with 1.3 l STOP solution
(0.5 mg/ml proteinase K, 0.5% SDS) and incubated for 20
min at 37◦C. After addition of 2 l native loading buffer
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Figure 1. Similar Exo1 phosphorylation pattern in response to dNTPs de-
pletion or DNA damage. (A) An EXO1-MYC culture was synchronized in
G1 with -factor pheromone and released into YPD medium for 210 min.
Samples were taken at the indicated times for flow cytometry analysis (left
panel) and immunoblot analysis (right panel). Exo1-MYC was detected
with -MYC antibody, and Rad53 and PGK were detected with -Rad53
and -PGK antibodies respectively. Exo1-MYC was analysed during un-
perturbed conditions in acrylamide gels in the absence or presence of Phos-
tag (indicated as − or +), and in the last case, Exo1 showed a constitutive
single band (arrow) plus a weaker upper band (asterisk). (B) EXO1-MYC
cells were blocked in G1 with -factor and then released into YPD medium
or in YPD containing either 0.2M HU or 0.033% MMS. The percentage
of budded cells after 120 min from -factor release in non-treated, HU or
MMS-treated cells was 98, 96 and 97%, respectively. Samples were taken
at G1 and at the indicated times during S phase for DNA content analysis
(upper panel) and immunoblot analysis for Exo1-MYC, Rad53 and PGK
as indicated in (A) (lower panel). For Exo1-MYC analysis, protein sam-
ples were run in Phos-tag gels and, like in (A), the arrow and the asterisk
points at the constitutively detected Exo1 bands, whilst the low mobility
bands marked as pExo1 (crochet) are specifically detected in the presence
8.0, 0.48% SDS) reaction products were separated by 10%
native PAGE in 1× TBE (90 mM boric acid, 90 mM Tris
base, 2 mM EDTA). For analysis of endonuclease activity,
reactions were stopped by the addition of 1 volume of 2×
formamide-loading buffer (80% formamide in 1× TBE),
boiled at 99◦C for 5 min and products were separated in
16% polyacrylamide, 7M urea-denaturing gels in 1× TBE.
Fluorescent products were detected by scanning fresh gels
at 488 nm in a Typhoon FLA9500 (GE Healthcare).
-phosphatase assay
Protein extracts were prepared as described (43) in the fol-
lowing buffer (6.6% Glycerol, 62.5 mM Tris base, 3% SDS)
and, then, diluted in RIPA buffer (50 mM Tris-HCL pH 8,
150 mM NaCl, 1% Np-40, 0.5% sodium deoxycholate, 0.1%
SDS). The resulting extracts were either treated with the
 protein phosphatase kit (New England Biolabs) or only
with the included buffer. Samples were then run in a Phos-
tag gel.
Two-dimensional electrophoresis
Genomic DNA was isolated using the QIAGEN Blood &
Cell Culture DNA Midi Kit following the manufacturer’s
instructions. Then, the purified DNA was digested using
XbaI and EcoRI, and separated by neutral/neutral 2D
agarose gel electrophoresis as previously described (58). The
DNA was transferred to a nylon membrane (Amersham
Hybond XL) for Southern Blotting. The fragments of in-
terest were detected with a P32 labelled DNA probe. Repli-
cation intermediates were quantified by calculating the per-
centage radioactivity signals in specific recombination inter-
mediates relatively to the monomer spot as described (59).
RESULTS
Exo1 is phosphorylated with similar dynamics during S phase
in response to DNA damage or nucleotide depletion
We started analysing post-translational modifications of
Exo1 during the cell cycle, in normal or perturbed condi-
tions in budding yeast. In the first place, we analysed Exo1
expression and presence of modifications during the cell cy-
cle in unperturbed conditions. An asynchronous culture of
an Exo1-MYC strain was synchronized in G1 with -factor
mating pheromone and released into fresh medium for 210
min, which covers approximately two cell cycles based on
flow cytometry and percentage of budded cell analysis (Fig-
ure 1A, left panel and Supplementary Figure S1A). Pro-
tein samples were taken at different time points to examine
Exo1 regulation by SDS-PAGE (Figure 1A, right panel),
and this analysis showed first, that Exo1 was present at
similar levels through the cell cycle as a single prominent
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
of HU or MMS. (C) -phosphatase assay of Exo1. Protein extracts from
HU-treated cells were either untreated, treated with -phosphatase (+) or
just with the phosphatase’s buffer (−). After the treatment, the extracts
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band and a weaker upper band (arrow and asterisk, respec-
tively, in Figure 1A) and second, that Exo1 mobility did not
change significantly at any stage in the absence or presence
of Phos-tag. As expected in the absence of genotoxic stress,
immunoblot analysis of Rad53 showed absence of Rad53
phosphorylation during the experiment.
Next, we compared Exo1 electrophoretic migration dur-
ing S phase in normal conditions and in response to nu-
cleotide depletion or DNA damage. In this case, G1 blocked
cells were released into S phase in fresh medium or in the
presence of 0.2M HU or 0.033% MMS, and samples were
taken to monitor DNA content and Exo1 modifications
along the experiment (Figure 1B). In these three situations,
the cells entered normally into S phase, as indicated by the
estimation of the budding index in all cases (>95% budded
cells after 120 min from -factor release). Regarding Exo1
post-translational modifications, as cells entered S phase in
the presence of either HU or MMS, a new set of bands
was detected but only when protein samples were analysed
in SDS-PAGE in the presence of Phos-tag (Figure 1B and
Supplementary Figure 1B-C), indicating that the protein is
modified at several sites in both conditions. A very simi-
lar pattern of modified bands was observed in the samples
treated with HU or MMS, and in both situations the Exo1
shift was detected from the beginning of S phase and it re-
mained as long as HU or MMS were present in the cul-
ture medium. The Exo1 shift correlated with checkpoint ac-
tivation under these conditions, as observed by analysing
Rad53 phosphorylation by immunoblot (Figure 1B). In HU
and MMS-treated samples, we observed Exo1 protein that
remained unmodified, and so it was present at the same po-
sition than Exo1 protein in the untreated samples (arrow
and asterisk in Figure 1B). Phosphatase treatment of pro-
tein extracts from HU-treated EXO1-MYC yeast cells con-
verted the slower migrating bands into a single faster band
(Figure 1C), indicating that the observed protein modifica-
tions correspond to Exo1 phosphorylation. Therefore, our
results indicate that Exo1 phosphorylation takes place with
similar kinetics during S phase in response to nucleotide de-
pletion and DNA damage.
Role of Mec1, Rad53 and Dun1 kinases in Exo1 phosphory-
lation in response to DNA damage or replicative stress
Although previous studies have shown that after genotoxic
stress Exo1 phosphorylation is dependent on checkpoint ki-
nases (46–49), the contribution of Mec1, Rad53 and Dun1
kinases to Exo1 phosphorylation under DNA damage or
nucleotide depletion has not been clarified. To answer this
point, we have compared Exo1 phosphorylation in response
to MMS or HU treatment in checkpoint proficient, dun1Δ,
rad53Δ and mec1Δ cells (all the strains share a sml1Δ back-
ground to allow survival of mec1Δ and rad53Δ mutants).
All the strains were synchronized in G1 by -factor treat-
ment and then released into S phase in the presence of MMS
or HU. Flow cytometry analysis indicated that in the four
strains DNA synthesis is blocked by HU, and DNA repli-
cation of damaged DNA proceeds very slowly in sml1Δ
and dun1Δ mutants, and faster in rad53Δ and mec1Δ cells
(Figure 2A and B), due to their inability to inhibit late ori-
gin firing as previously reported (23). Immunoblot analysis
showed that whereas in the absence of Dun1 the Exo1 phos-
phorylation pattern is very similar to the one in the control
strain (sml1Δ cells), the absence of Rad53 or Mec1 abolishes
Exo1 phosphorylation in both situations, and that was ob-
viously concomitant with lack of Rad53 phosphorylation
(Figure 2A and B). Given that Rad53 is downstream Mec1
in the checkpoint-signalling pathway and Dun1 does not
seem involved, our results indicate that Exo1 phosphoryla-
tion in response to DNA damage or nucleotide depletion is
primarily Rad53-dependent.
Exo1 is phosphorylated at multiple sites in response to DNA
damage or nucleotide depletion
If Exo1 suffers multiple phosphorylations after checkpoint
activation and it is Rad53 dependent, it would be useful to
identify all the relevant Rad53-dependent phosphorylation
sites to be able to analyse the role of this phosphorylation
in the regulation of the protein, and by extension in fork
stability. Four major phosphorylation sites have been pre-
viously identified in Exo1 after MMS exposure or telom-
ere uncapping, serines S372, S567, S587 and S692, (46,47);
however, when these four residues were mutated to gener-
ate phospho-mimic mutants, the resulting exo1–4SD alleles
showed a significantly milder phenotype than the one con-
ferred by EXO1 deletion (47,60), suggesting that although
phosphorylation seems to inhibit protein function, phos-
phorylation at these four sites is not sufficient for a com-
plete regulation of the protein and Exo1 might be phospho-
rylated at additional sites.
Thus, to identify additional Rad53-dependent phospho-
rylation sites, we performed an in vitro kinase assay with
purified Rad53 and a cellulose membrane containing an ar-
ray of peptides corresponding to the entire Exo1 amino acid
sequence, and we identified 6 Ser/Thr that were phosphory-
lated by Rad53 in vitro (Supplementary Figure S2A). Two of
these phosphorylation sites, S372 and S587, coincided with
previously reported sites phosphorylated in vivo (46,47).
When these six residues were converted to alanine, that
blocks phosphorylation, the corresponding Exo1–6A pro-
tein showed a significant decrease in the phosphorylation
shift upon MMS treatment (Supplementary Figure S2B).
However, the substitution of these six Ser/Thr residues for
aspartic acid, whose negative charge mimics phosphoryla-
tion of the residue, did not suppress replication fork collapse
in rad53 mutants (Supplementary Figure S2C), contrary to
what EXO1 deletion does, questioning if Exo1 phospho-
rylation by Rad53 was inhibiting the deleterious effect of
Exo1 in fork integrity. One explanation for this phenotype
might be that in the absence of the preferential phosphory-
lation sites, additional sites can be phosphorylated, or al-
ternatively, additional phosphorylation sites may have been
missed in our analysis. In fact, a residual phosphorylation
shift can be observed in exo1–6A extracts upon MMS treat-
ment (Supplementary Figure S2B).
To overcome this problem, and considering that three
different approaches ((46,47) and this work) failed to de-
tect all the possibly functional phosphorylation residues in
Exo1, we decided to substitute for either alanine or aspartic
acid the serines or threonines residues that follow the amino
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Figure 2. Exo1 phosphorylation is Rad53 dependent in response to dNTPs depletion or DNA damage. sml1Δ, sml1Δ dun1Δ, sml1Δ rad53Δ and sml1Δ
mec1Δ strains were synchronized with -factor and released into YPD medium in the presence of either 0.2M HU (A) or 0.033% MMS (B), and samples
were taken at the indicated times. Flow cytometry analysis is shown in left panels, whilst immunoblots of protein extracts for Exo1-MYC, Rad53 and PGK
are shown in right panels. For Exo1-MYC analysis, proteins were resolved on a Phos-tag polyacrylamide gel.
amino acid, described for potential Rad53 phosphorylation
sites (46). Exo1 contains 702 amino acids residues, from
which 97 are serines and threonines, and 23 of them fulfil
this motif. Most of these 23 Ser/Thr residues were located
in the C-terminal region, with only a few sites located in
the N-terminal portion of the protein and none of them
were altering the conserved nuclease consensus sequence
(55). It has been shown that deletion of both EXO1 and
the flap-endonuclease RAD27 is lethal, presumably because
a defective processing of Okazaki fragments (36,61); how-
ever, yeast strains expressing exo1–23A or exo1–23D did not
show synthetic lethality in combination with RAD27 dele-
tion (Figure 3A and Supplementary Figure S3A-B), indicat-
ing that the Exo1–23A and Exo1–23D proteins are capable
to perform an essential function, likely Okazaki fragment
maturation, and therefore, the 23 Ser/Thr residues selected
for the analysis are not critical for protein function. When
the phosphorylation status of these mutant alleles was ex-
amined, we observed that in the exo1–23A allele the phos-
phorylation shift of the protein was abolished in Phos-tag
SDS-PAGE after both HU or MMS treatment (Figure 3B
and C, respectively), indicating that most of the in vivo phos-
phorylation sites have been eliminated. As expected, the mi-
gration of the Exo1–23D protein was slower than Exo1 or
Exo1–23A proteins at any time point, due to the negative
charge conferred by the aspartic acid residues. Moreover,
the electrophoretic mobility of Exo1–23A o Exo1–23D pro-
teins was undistinguishable in the presence or absence of
Rad53, indicating the lack of regulation by phosphoryla-
tion from this kinase in these mutants (Figure 3D).
An exo1-23D phospho-mimic allele suppresses fork collapse
and improves survival in rad53 mutants in HU
To examine the correlation between Exo1 phosphorylation
and fork stability, we analysed the stability of replication
forks by 2D gel in rad53 mutants carrying these different
phospho-mutant versions of Exo1.
To this end, rad53Δ, rad53Δexo1Δ, rad53Δexo-23A and
rad53Δexo-23D cells were synchronized in G1 phase and
released into rich medium containing 0.2 M HU for 2 h,
and DNA content was measured by flow cytometry every
30 min (Supplementary Figure S4A). We analysed replica-
tion intermediates arising from the activation of the early
origin ARS305, and we observed that in all cases replica-
tion bubbles accumulates within the fragment from 30 to 60
min after G1 release, due to replication fork stalling in the
presence of HU. In rad53Δ cells replication bubbles are
barely detectable from 90 min onwards and large Ys no-
tably decrease, due to the collapse of the replication forks
in the absence of a functional checkpoint (24), whereas in
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Figure 3. Analysis of viability and electrophoretic mobility of Exo1-phosphorylation mutants. (A) Drop assay of exo1Δ, exo1–23A, exo1–23D, rad27Δ,
rad27Δ exo1–23A and rad27Δ exo1–23D strains. 1:5 serial dilutions of the indicated strains were spotted on YPD plates and incubated at 30◦C for 3 days.
(B and C) EXO1-MYC, exo1–23A-MYC and exo1–23D-MYC cells were synchronized with -factor and released into YPD in the presence of either 0.2M
HU (B) or 0.033% MMS (C), and samples were collected at the indicated times. Left panels show DNA content analysed by flow cytometry and right panels
show immunoblots of Exo1-MYC, Rad53 and PGK. A Phos-tag gel was used for Exo1-MYC western blot analysis. (D) sml1Δ exo1–23A-MYC, sml1Δ
rad53Δexo1–23A-MYC, sml1Δ exo1–23D-MYC and sml1Δ rad53Δexo1–23D-MYC cells were synchronized with -factor and released in the presence of
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stable through the experiment indicating that EXO1 dele-
tion suppresses fork collapse in HU as previously described
(29). Interestingly, the exo1–23D phospho-mimic allele also
suppresses fork collapse in rad53 mutants very efficiently,
whereas the exo1–23A allele does not (Figure 4A and Sup-
plementary Figure S4B). These results argue that Rad53
regulates fork stability after stalling mainly through Exo1
phosphorylation.
EXO1 deletion suppresses fork collapse but is completely
ineffective in suppressing the sensitivity of rad53 mutants to
HU (41), and therefore, an Exo1-independent mechanism
might be additionally required to support cell survival in the
presence of HU. In fact, it has been shown that both Rad53-
dependent negative regulation of Exo1 and RNR induction
are important mechanisms for the viability of rad53 mutants
in the presence of replicative stress (43). This enzymatic
complex is the target of HU (62), and on top of preserving
stable replication forks in rad53exo1 cells, new expression
of RNR seems to be important to promote DNA synthesis,
which is essential for cell viability after HU-induced stalling
(43).
Similar to EXO1 deletion, exo1–23D phospho-mimic al-
lele also suppresses fork collapse (Figure 4A) but it does
not rescue survival in rad53 mutants in HU (Supplementary
Figure S5). As we were interested in the role of Exo1 phos-
phorylation in fork stability and, perhaps, in cell survival in
the presence of HU, we performed an HU-sensitivity assay
with rad53Δ, rad53Δ exo1Δ, rad53Δ exo1–23A and rad53Δ
exo1–23D strains in conditions that induce RNR or not.
In these strains, the RNR2, RNR3 and RNR4 genes were
expressed from the inducible GAL1–10 promoter. Our re-
sults recapitulated that the combination of EXO1 deletion
and RNR expression significantly improved resistance to
HU in a galactose-dependent manner, and the same was
true with the exo1–23D allele but not with the exo1–23A
allele (Figure 4B). These results indicated that Exo1 phos-
phorylation promotes fork stability and resistance to HU in
rad53Δ mutants. However, as mentioned above, cell viabil-
ity in the presence of HU requires also Exo1-independent
mechanisms, such as RNR expression, between others.
exo1-23D phospho-mutant cells are impaired in the repair of
MMS-induced DNA lesions but are proficient in Okazaki
fragment maturation
To understand how replication fork stability was rescued
in rad53 mutants by exo1–23D, but not by the exo1–23A
allele, we examined the properties of these Exo1 phospho-
mutants. Regarding sensitivity to MMS, exo1–23A or exo1–
23D mutant strains exhibited different phenotypes. Thus,
the exo1–23A allele was not sensitive to MMS, whereas
the phospho-mimic exo1–23D allele showed a significant
sensitivity to MMS, similarly to the one observed in an
EXO1 deletion strain (Figure 5A). Exo1 activity is involved
in the repair of MMS lesions, and therefore, is expected
to be beneficial for viability in the presence of this drug
(39). So, the MMS sensitivity of the exo1–23D allele sug-
gests that phosphorylation might impair the activity of
Exo1 involved in repair. To test this possibility, we com-
pared the MMS sensitivity of this exo1–23D allele and
some nuclease deficient mutants of Exo1 previously de-
scribed, such as exo1-D173A and exo1-E150D (55). The
biochemical characterization of these mutants have previ-
ously shown that the exo1-D173A allele was completely
defective for both the dsDNA 5′-3′ exonuclease and flap-
endonuclease activities, whereas the exo1-E150D was defi-
cient for dsDNA 5′-3′ exonuclease activity but retained sub-
stantial flap-endonuclease activity (55). Thus, we compared
the MMS sensitivity of wild-type EXO1, exo1–23A, exo1–
23D, exo1-D173A, exo1-E150D and exo1Δ strains. We first
discarded a negative effect of the MYC epitope in protein
function (Supplementary Figure S6A), and we checked by
western blot that the level of Exo1–23A and Exo1–23D pro-
teins was like the Exo1-wild-type version, both in expo-
nentially growing cells or in response to genotoxic treat-
ment during S phase (Supplementary Figure S6B). There-
fore, any observed differences in MMS sensitivity would
not be attributed to different Exo1 protein levels in these
phospho-mutants. As shown in Figure 5B, all the strains
grew with similar rates on rich media (YPD), but exo1-
D173A and exo1-E150D strains exhibited a marked sensi-
tivity to MMS as reported previously (55), comparable with
the one showed by the exo1Δ strain. Interestingly, indepen-
dently of having flap-endonuclease activity or not, both nu-
clease mutants were similarly sensitive, supporting that the
exonuclease activity is the one involved in MMS resistance.
Therefore, if viability in MMS correlates with a proficient
5′-3′ exonuclease activity, the viability drop of the exo1–23D
mutant, similar to the one observed in exo1-D173A, exo1-
E150D and exo1Δ strains, argues that this strain might be
also deficient in exonuclease activity. This is not the case for
exo1–23A mutants that show no sensitivity to MMS.
DNA resection generates ssDNA, which is a signal to
trigger DNA damage checkpoint activation (63), and it has
been recently reported that Rad53 phosphorylation during
S phase in the presence of MMS lesions is dependent on
Exo1 activity (49). Therefore, we reasoned that a defective
5′-3′ exonuclease exo1 allele, would affect checkpoint acti-
vation. To test this idea, we compared Rad53 phosphoryla-
tion in EXO1+, exo1Δ, exo1-E150D, exo1–23D and exo1–
23A strains during S phase in response to MMS treatment.
Our results indicated that although checkpoint activation
was not compromised in any of the strains, Rad53 phos-
phorylation was delayed at early time points in the exo1-
E150D and exo1–23D strains, just like the exo1Δ strain,
compared with an EXO1+ or an exo1–23A strain, in which
Rad53 phosphorylation was observed at 15 min after entry
into S phase in the presence of MMS (Figure 5C, asterisks).
In exo1-E150D and exo1–23D strains, Rad53 phosphoryla-
tion was not clearly detected until 30 min and beyond, sim-
ilarly as shown in the absence of Exo1 (Figure 5C).
In G1, ssDNA arising from DNA lesions also triggers
checkpoint activation in an Exo1-dependent manner (64),
and, in particular, MMS lesions induced during G1 led to
checkpoint activation during the next replication cycle (49).
In this case, a marked delay in checkpoint activation was
shown in the absence of Exo1 (49), and therefore, we de-
cided to corroborate our previous result (Figure 5C) by
analysing Rad53 phosphorylation in the same Exo1 mu-
tants under these conditions. In this case, we observed that
Rad53 phosphorylation was rapidly reached at 15 min af-
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Figure 4. exo1–23D phospho-mimic mutant rescues fork collapse in a rad53Δ mutants in the presence of replicative stress. (A) Two-dimensional gel elec-
trophoresis analysis of DNA replication intermediates at the ARS305 origin from exo1–23A/23D mutants and exo1Δ mutant in a rad53Δ background.
Cells were synchronized with -factor and released into YPD in the presence of 0.2M HU for 2 h. Samples were taken every 30 min, DNA was purified,
and DNA replication intermediates were analysed by 2D gel electrophoresis. The arrows point to replication bubbles that persist after 90 min of nucleotide
depletion, indicative of fork stability. (B) The 1:5 serial dilutions of the indicated strains grown in YEP-raffinose were spotted in YEP medium containing
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Figure 5. exo1–23D phospho-mimic mutant shows an exonuclease deficient and flap-nuclease proficient phenotype. (A and B) The 1:5 serial dilutions of
the indicated strains were tested for sensitivity to 0.015% MMS in YPD plates by using a drop assay. (C) Analysis of Rad53 phosphorylation during S
phase in the presence of MMS in the indicated strains. Cells were synchronized in G1 and released into S phase in YEPD medium containing 0.033%
MMS. Rad53 and PGK were detected by immunoblot with -Rad53 and -PGK antibodies respectively. An * has been used to mark the 15 min time
point where Rad53 phosphorylation is detected in EXO1+ and exo1–23A strains, but not in the others. (D) Analysis of RAD53 phosphorylation in the
indicated strains. Cells were arrested in G1, treated with 0,08% MMS for 30 min and then released into S phase in YEPD medium. Rad53 and PGK were
detected as described in (B). (E) Drop assay of the indicated strains in YPD plates as described in (A).
but the exo1-E150D and exo1–23D strains exhibited a fur-
ther delay in Rad53 phosphorylation, which started to be
weakly detectable at 45 min (Figure 5D).
These results indicated that Exo1-mediated resection is
affected in exo1–23D and exo1-E150D mutants, but not in
exo1–23A, supporting that the phospho-mimic allele exo1–
23D is also 5′-3′ exonuclease defective.
Regarding flap-endonuclease activity, its requirement to
survive in the absence of RAD27 has been previously
demonstrated by showing that an exo1-E150D mutant is
viable in combination with RAD27 deletion, but an exo1-
D173A is synthetic lethal with RAD27 deletion (55). We
compared the genetic interactions between these nuclease
deficient mutants with RAD27 and the one exhibited by the
phospho-mimic exo1–23D allele. Our results recapitulated
that an exo1-D173A rad27Δ strain was unviable, like the
exo1Δ rad27Δ one, but the exo1-E150D rad27Δ strain was
viable (Supplementary Figure S3A). Interestingly, it exhib-
ited similar growth than an exo1–23D rad27Δ strain, judg-
ing by the similar colony size reached in YEPD plates (Fig-
ure 5E), arguing that the exo1–23D allele maintains flap-
endonuclease activity to promote survival in the absence of
RAD27.
Replication fork collapse in rad53 mutants is independent of
Exo1-flap endonuclease activity
Next, we reasoned that if Exo1–23D maintains flap-
endonuclease activity, but replication forks were stable in
rad53 exo1–23D mutants in HU, Exo1 flap-endonuclease
activity might not be involved in fork degradation and we
could take advantage of the different catalytic activities of
the nuclease mutants exo1-D173A and exo1-E150D to de-
termine the nuclease activity involved in fork collapse in
rad53 mutants experiencing replication stress. Thus, we syn-
chronized rad53Δ exo1Δ, rad53Δ exo1-E150D and rad53Δ
exo1-D173A cells in G1 and released them in fresh media in
the presence of 0.2M HU. We monitored DNA content by
flow cytometry along the experiment (Supplementary Fig-
ure S7A) and performed 2D gel analysis of DNA replication
intermediates on ARS305. We observed that in the rad53Δ
exo1-D173A cells the replication bubbles and large Ys were
stable through the 2 h of analysis (Figure 6 and Supplemen-
tary Figure S7B). These cells are catalytically inactive for
both dsDNA 5′-3′ exonuclease and flap-endonuclease ac-
tivities and, therefore, the stability of replication forks in
this strain evidences that fork collapse is linked to Exo1
nuclease activity. Remarkably, rad53Δ exo1-E150D cells
were equally proficient in preserving fork integrity despite
harbouring flap-endonuclease activity, strongly support-
ing that flap-endonuclease activity is not involved in fork
collapse of rad53 mutants in the presence of replicative
stress. These results point out for the first time the en-
zymatic activity responsible of the collapse of replication
forks in rad53 mutants, which would be relevant to under-
stand the substrates and DNA transitions formed in repli-
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Figure 6. Fork collapse in rad53Δ mutants is linked to Exo1′s exonuclease activity but not to its flap-endonuclease activity. Two-dimensional gel elec-
trophoresis analysis of DNA replication intermediates from exo1-E150D rad53Δ, exo1-D173A rad53Δ and exo1Δ rad53Δ mutants were performed as
described in Figure 4.
The 14-3-3 proteins are not required for maintaining fork sta-
bility in rad53 exo1-23D mutants
14-3-3 proteins have been proposed to regulate Exo1 phos-
phorylation and, in turn, fork processing and stability (48).
It was therefore possible that instead of an irrelevant role
of Exo1 flap-endonuclease activity in fork degradation, the
interaction between the 14-3-3 proteins and the exo1–23D
version of Exo1, which mimic phosphorylation (Figure 3
B–D), would limit its flap-activity on replication fork sub-
strates and explain the suppression of fork collapse ob-
served in rad53Δ exo1–23D mutants in HU. We have con-
firmed the interaction between Exo1 and Bmh1, the major
isoform of the 14-3-3 proteins, and shown that it is specif-
ically detected in HU-treated cells during S phase (Figure
7A). Moreover, we have shown that the Exo1/Bmh1 in-
teraction is largely dependent on Rad53 (Figure 7A), but
whether Rad53-dependent Exo1 phosphorylation is impor-
tant for the 14-3-3 protein binding is not known. To explore
this possibility, Bmh1-bound Exo1 was resolved in Phos-
tag gels, and we observed phosphorylated forms in the co-
immunoprecipitated Exo1 fraction (Figure 7B), indicating
that 14-3-3 proteins interact with phosphorylated Exo1. In-
terestingly, this interaction is preserved in the Exo1–23D
phospho-mimic version (Figure 7C), supporting that it be-
haves like a functional phospho-mimic. On the contrary, the
interaction was not detected with the phospho-null Exo1–
23A version, strongly arguing that Exo1 binding to 14-3-3
proteins is phospho-dependent.
To examine whether the suppression of fork collapse ob-
served in the rad53Δ exo1–23D strain was mediated by the
14-3-3 proteins, we analysed the stability of replication forks
in a rad53Δ exo1–23D bmh2Δ bmh1–266 strain, in which all
the 14-3-3 proteins are not functional. When replication in-
termediates were analysed by 2D gel under conditions of
nucleotide depletion, we observed that fork integrity was
maintained in both the rad53Δ exo1–23D and the rad53Δ
exo1–23D bmh2Δ bmh1–266 strains (Figure 7D and Sup-
plementary Figure S8) and, therefore, the 14-3-3 proteins
are not required to maintain fork stability in these mutants.
A plausible explanation of our results is that exo1–23D sup-
presses fork collapse in rad53 mutants because it is defective
in exonuclease activity, which as shown above (Figure 6) is
likely responsible of the degradation of replication forks.
exo1-23D phospho-mimic mutants are exonuclease-deficient
Until now, all the in vivo phenotypes analysed indicated that
the exo1–23D allele appears to be exonuclease deficient and
flap-endonuclease proficient to some extent, whereas the
exo1–23A seems not affected in activity. To test this predic-
tion, we investigated the in vitro nuclease activities of Exo1–
23A and Exo1–23D phospho-mutants, in parallel with
previously biochemically characterized Exo1, Exo1-E150D
and Exo1-D173A proteins (55). In each case, MYC-tagged
proteins were immunoprecipitated from S-phase cells, and
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Figure 7. Suppression of fork collapse in exo1–23D rad53Δ mutants is independent of the 14-3-3 proteins. (A) Analysis of Bmh1-PK and Exo1-MYC
interaction in EXO1-MYC BMH1-PK and EXO1-MYC BMH1-PK rad53Δ strains. G1-blocked cells were released into YPD medium containing or not
0.2M HU for 90 min. Cells were harvested and proteins were pulled down with -MYC antibody, and a fraction of the Whole Cell Extract (WCE), and the
co-immunoprecipitated proteins (IP) are shown in the immunoblot. Exo1-MYC was detected with -MYC antibody and Bmh1-PK with -PK antibody.
(B) Co-immunoprecipitation assay of Exo1-MYC as described in (A). Proteins were pulled down with -PK antibody. Analysis of Phostag-SDS page from
WCE and IP proteins are shown in the lower panel. (C) Immunoblot of a co-immunoprecipitation assay of an EXO1-MYC BMH1-PK, an exo1–23D-
MYC BMH1-PK and an exo1–23A-MYC BMH1-PK strains in HU as in (A) is shown in the upper panels. Strains that lacked MYC-tagged Exo1 were
used for the co-immunoprecipitation assay shown in the lower panels (EXO1+BMH1-PK, exo1–23D BMH1-PK and exo1–23A BMH1-PK). A fraction
of the supernatant (Sup.) is also shown in the immunoblot. (D) Analysis of replication intermediates by 2D gel electrophoresis at the ARS305 in rad53Δ
exo1–23D bmh2Δ bmh1–266 strains in the presence of 0.2 M HU. The graphs show the quantification analysis of replication bubbles.
strates that allow specific detection of 5′ flap-endonuclease
(splayed arm, Figure 8A) or 5′-3′ exonuclease activitiy (5′-
recessed dsDNA, Figure 8B).
In the assay with the splayed arm, the endonucleolytic
processing of the structure would result in the appearance
of an 11-nt labelled product. As shown in Figure 8A, all
Exo1 variants displayed endonuclease activity, as judged
by the conversion of the full-length oligonucleotide into
the smaller product, except in those reactions performed
with an untagged strain or with IP-Exo1-D173A. When the
enzymatic activity of these Exo1 variants was assayed on
a 5′recessed dsDNA substrate, wild-type Exo1 and Exo1–
23A exhibited 5′-3′ exonuclease activity whereas the Exo1–
23D mutant was clearly deficient for this activity (Figure
8B), supporting our initial premise. Furthermore, Exo1–
23D catalytic activity pattern mirrors the one observed in
Exo1-E150D, whereas Exo1-D173A lacked both endonu-
clease and 5′-3′ exonuclease activities as previously reported
(55).
These results confirm that Exo1–23A was proficient in
both 5′ flap-endonuclease and 5′-3′ exonuclease activities,
whereas Exo1–23D displayed endonuclease activity, but a
marked deficiency in 5′-3′ exonuclease activity. These results
are in agreement with the in vivo phenotypes of the Exo1
phospho-mutant strains and strongly suggest that phospho-
rylation has a direct inhibitory effect on the 5′-3′ exonucle-
ase activity of Exo1.
DISCUSSION
There are differences in the regulation of replication forks
in the presence of dNTP depletion or DNA damage. In
both situations, Exo1 negative regulation is required to pre-
serve fork stability, but whereas in MMS this inhibition re-
stores replication fork progression (41), in HU it does not
(29,41). We wondered whether this could be due to a differ-
ent Rad53-dependent regulation of Exo1 in each circum-
stance. Rad53 is indeed differently phosphorylated in re-
sponse to different genotoxic stresses (65–67) and distinct
phosphatases are also involved in the removal of phospho-
rylation in each situation (68–71). However, whether these
differences in Rad53 regulation depending on the nature of
the DNA lesion, are also extrapolated to downstream events
of the checkpoint response such as the post-translational
modifications of checkpoint targets, is not known.
Although a precise proteomic approach will be necessary
to determine whether the same phosphorylation residues
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Figure 8. In vitro nuclease activity of Exo1 variants. (A) Extracts from
EXO1-MYC, exo1–23A-MYC, exo1–23D-MYC, exo1-E150D-MYC and
exo1-D173A-MYC strains were prepared from S-phase cells and Exo1-
MYC variants were detected in the whole cell extracts (WCE) and immuno-
precipitates (MYC-IP) by western blotting (upper panels). The analysis of
5′ flap-endonuclease activity of the immunoprecipitated Exo1 variants us-
ing a 5′-6FAM-labelled splayed arm is shown in the lower panel. ‘C’, con-
trol reaction using immunoprecipitates from an untagged strain; ‘-’, reac-
tion without extract. The 11-nt product resulting from the endonucleolytic
cleavage of the substrate is indicated. (B) Exonuclease activity in immuno-
precipitates from the same strains as in (A) was assessed using a 5′-recessed
double-stranded DNA with 3′-6FAM-labelling. The product of 5′-3′ ex-
onuclease activity is indicated.
pletion, our data suggests that there is not a clear distinct
Exo1 regulation after MMS or HU treatment, as in both
situations Exo1 phosphorylation is Dun1-independent and
Rad53-dependent, and a very similar and reproducible pat-
tern of phosphorylated bands was observed in the different
experiments performed along the study (Figure 1B, Supple-
mentary Figure S1C, Figures 2A-B and 3B-C). Moreover,
previous results (46–48,72) and ours (this work) argue that
phosphorylation sites are redundant, probably to guaran-
tee the transduction of the checkpoint signal through the
cascade in the face of impediments that might block or oc-
cupy some of the prevalent phosphorylation sites. This no-
tion is supported by the fact that several Exo1 phosphory-
lation residues have been found by different approaches and
conditions, which probably represent the preferential ones,
but other sites identified in different studies do not over-
lap (46–48); (this work). In addition, eliminating a subset
of phosphorylation sites was not sufficient to abolish the
phosphorylation shift of Exo1 in vivo (49) (and Supplemen-
tary Figure S2B of this work), or to confer a significant phe-
notype to the resulting strains carrying the modified ver-
sions of the protein, indicating that the regulation of Exo1
is achieved through multiple phosphorylations. Similarly, a
multitude of phosphorylation sites have been estimated in
human EXO1 (50,53,73), and mutations in specific residues
like Ser 714 identified as a phosphorylation site in vivo,
was not sufficient to abrogate checkpoint-dependent regu-
lation or to avoid EXO1 degradation after replicative stress
(50). Other Rad53 substrates are also hyper-phosphorylated
(74), indicating that phosphorylation at multiple sites is a
common mechanism to transduce the signal of the S phase
checkpoint kinases to their targets.
Regarding Exo1 as an important factor involved in fork
stability (29,41), and knowing that Exo1 is phosphorylated
in a checkpoint dependent manner (46–49), an important
issue was to investigate the correlation between Exo1 phos-
phorylation and fork stability. Our results have shown that
the exo1–23D mutant, that mimics constitutive phospho-
rylation (Figure 3B and C), rescues fork collapse in rad53Δ
mutants treated with HU (Figure 4A) as efficiently as EXO1
deletion, arguing that the stability of replication forks is
achieved mainly through Exo1 phosphorylation. By this, we
mean that replication forks of rad53Δ exo1Δ and rad53Δ
exo1–23D strains, when analysed by standard 2D gels, show
stable bubbles and large Y molecules along the HU treat-
ment (Figure 4A and Supplementary Figure S4B), indica-
tive of suppression of fork collapse as previously reported
(29). Our results do not exclude that other unusual replica-
tion intermediates that are not detectable by conventional
2D gels may be transitory at replication forks under these
conditions. Nevertheless, the important point is that the
phospho-mimic exo1–23D allele parallels suppression of
fork collapse in rad53 mutants as the absence of Exo1 does.
What makes Exo1 the more relevant nuclease involved in
fork degradation, despite being non-essential and redun-
dant with other proteins with the same catalytic activities
remains to be elucidated.
Remarkably, we observed a clear correlation between
suppression of fork collapse and increased viability in the
presence of HU in the phospho-mimic mutants (Figure
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of dNTP depletion requires stable replication forks, but not
only, and other events, like RNR induction, are addition-
ally necessary to promote replication resumption and sur-
vival under these conditions (43). Our results showed that
the exo1–23D allele and EXO1 deletion confers similar HU-
resistance in rad53 mutants upon RNR induction, suggest-
ing that in both cases replication forks must be similarly
competent to restart and finish replication to some extent
(43), which is essential to support viability. This fact ex-
cludes that other Exo1 regulatory mechanism distinct than
phosphorylation is required for the competence to restart
stalled forks when appropriate conditions are restored.
Thus, the regulation of replication forks after replicative
stress is a complex task and involves different mechanisms.
Rad53-dependent phosphorylation of Exo1 preserves fork
stability, Rad53-dependent RNR induction promotes fork
restart (43,75), and several factors such as the DNA heli-
cases Rrm3 and Pif1 (25), BLM helicases (76), the nucleases
Dna2, Sae2 and Mus81 (45–46,50,77–80), and the DNA
polymerase –primase complex (81,82) have been proposed
to also contribute to control fork restart, fork reversal or
coupling between leading and lagging strands synthesis in
yeast and human cells. Although how the S phase check-
point does coordinate all these factors to promote fork sta-
bility and restart after replication blockage has not been elu-
cidated yet.
Rescue of fork collapse was also recapitulated in the ab-
sence of Exo1 nuclease activity, since the nuclease-dead
(ND) mutant exo1-D173A reproduces the suppression of
fork collapse (Figure 6), indicating that fork collapse was
dependent on its nuclease activity. This result also high-
lights that merely the presence of Exo1 is not deleterious
for the integrity of replication forks and discard a possi-
ble structural role of Exo1 on fork stability. Interestingly, in
both nuclease deficient mutants (rad53Δ exo1-D173A and
rad53Δ exo1-E150D) replication forks are stabilized, de-
spite the fact that exo1-E150D maintains substantial flap-
endonuclease activity (55), arguing that fork collapse in the
absence of a functional checkpoint is specifically dependent
on the exonuclease activity of Exo1. We cannot rule out
the possibility that the residual flap-endonuclease activity
of exo1-E150D could be insufficient to degrade replication
forks. However, the flap-endonuclease activity of an exo1-
E150D strain is sufficient to keep cells alive, with a good
fitness in the absence of RAD27 (Figure 5E and Supplemen-
tary Figure S3A), indicating that it possesses enough flap-
endonuclease activity to perform an essential function, be-
ing most likely Okazaki fragment processing as it has been
suggested (55).
Similarly, the exo1–23D strain did not show synthetic
lethality with RAD27 deletion (Figures 3A, 5E and Supple-
mentary Figure S3), pointing out two important facts: first,
that Exo1–23D also conserves flap-endonuclease activity,
and second that it is, therefore, a functional protein capable
of performing a vital step of DNA replication. However, we
cannot exclude that protein function might be affected by
these 23 modifications to some extent. This result let us to
hypothesize that phosphorylation could have a distinct ef-
fect on the exonuclease and flap-activities of Exo1. Several
in vivo phenotypes exhibited by exo1–23D were indicative
of a defective 5′-3′exonuclease activity, such as similar sen-
Figure 9. Scheme of potential Exo1′s substrates that may be available dur-
ing replicative stress. (A) Gapped molecules at nascent strands. (B) Re-
versed forks. (C) Long flaps, which could be also processed by Dna2 and/or
Rad27.
sitivity to MMS as an exo1Δ or an exo1-ND strain (Fig-
ure 5B) (39) and a similar delay in Rad53 phosphorylation
(Figure 5C and D) (49). In agreement with this idea, the
in vitro nuclease assays demonstrated that the Exo1–23D
phospho-mimic variant possessed endonuclease activity but
was clearly deficient for 5′-3′exonuclease activity (Figure 8).
Thus, we propose that checkpoint-dependent phosphoryla-
tion of Exo1 specifically inhibits the exonuclease activity of
Exo1, responsible for the collapse of stalled forks.
One possibility to explain this regulation would be that
the 5′-3′exonuclease activity of Exo1 is specifically detri-
mental to the integrity of replication forks after replicative
stress because it acts on several key substrates generated or
exposed in checkpoint mutants after fork stalling (Figure
9). One of these substrates is probably the 5′ end of gaps
present in the nascent strands of HU-treated rad53 mutant
cells (Figure 9A), possibly originated after uncoupling be-
tween DNA unwinding by replicative helicases and DNA
synthesis or due to defects in leading or lagging strand syn-
thesis (32). Resection of the gap ends by Exo1 could explain
the accumulation of single-stranded regions found at stalled
forks in rad53 mutants in HU (29), which can possibly pro-
mote fork reversal. Reversed forks are in fact, other poten-
tial substrate for the 5′-3′ exonuclease activity of Exo1 (Fig-
ure 9B), which have been also observed in rad53 cells upon
HU treatment (26,29). Reversed forks are DNA structures
represented by four-branched molecules, which can arise
from re-annealing of the parental strands and extrusion or
degradation of the nascent strands, although the precise ori-
gin of these unusual structures and their role in fork stability
and restart is not totally clear (32). Which seems clear is that
Exo1 5′-3′exonuclease activity participates in the nucleolytic
processing of these DNA substrates, because elimination
of Exo1 counteracts the accumulation of ssDNA gaps at
nascent strands and increases the rate of fork reversal (29).
A similar role for human EXO1 in the resection of reversed
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posed that BRCA2 protects the regressed arms of reversed
forks from nucleolytic degradation by the CtIP, MRE11 and
EXO1 nucleases (83).
Besides a plausible deleterious effect of unscheduled 5′-
3′ exonuclease activity on replication forks, the 5′ flap-
endonuclease activity of Exo1 might be favourable to cope
with some toxic DNA structure generated at arrested repli-
cation forks in checkpoint mutants. In fact, the formation of
long 5′ flaps at the lagging strand of uncoupled replication
forks have been proposed (84), which would be processed by
flap-endonucleases such as Exo1 to avoid the formation of
pathological structures at forks (Figure 9C). Although dur-
ing unperturbed replication, other flap-endonucleases like
Rad27 and Dna2 are mainly responsible of the processing
of long flaps generated during Okazaki fragment processing
(85), in conditions that induce fork stalling the complexity
of the discontinuous synthesis of the lagging strand would
require additional mechanisms to preserve fork structure.
A high number of Okazaki fragments must be processed
per replication cycle (86), and in conditions that induce
fork stalling and strand displacement, the concerted ac-
tion of several flap-endonucleases such as Rad27-Dna2-
Exo1 might represent an advantageous backup mechanism
to guarantee proper processing of thousands of unusually
long flaps that otherwise would led to the generation of toxic
DNA structures at replication forks (Figure 9C). In fact, the
contribution of several flap-endonucleases like Exo1 and
Dna2 in counteracting the formation of unusual DNA repli-
cation intermediates in checkpoint defective cells exposed
to replication stress has been proposed (45). Accumulation
of long ssDNA flaps have been observed by electron mi-
croscopy in the absence of Dna2 (87); however, these struc-
tures have not been detected at stalled replication forks in
rad53 mutants in the absence of Exo1. Therefore, the Exo1
contribution to long ssDNA flaps processing is currently
uncertain.
It is worth noting that although other nucleases might
help to eliminate aberrant replication intermediates, which
can be beneficial under some circumstances, our results
strongly argue that Rad53-dependent Exo1 regulation,
through direct inhibition of its exonuclease activity, is
enough to maintain stable replication forks after dNTP de-
pletion in budding yeast.
Besides nuclease activity, Exo1 phosphorylation could
also regulate the protein’s stability, interactions and/or cel-
lular localization. In relation with protein stability, it has
been previously shown that in response to replicative stress,
ATR-dependent phosphorylation of human EXO1 induces
polyubiquitylation and proteasome-mediated degradation
(50,51), although this regulatory mechanism does not seem
to operate in budding yeast. In this case, Exo1 protein lev-
els are not affected by phosphorylation in response to HU
((48), Figure 1B and Supplementary Figure S1C) or MMS
(Figure 1B and Supplementary Figure S1C). Moreover,
the level of expression of the phospho-null Exo1–23A or
phospho-mimic Exo1–23D versions generated in this study
were not substantially different from the wild-type Exo1
protein (Supplementary Figure S6B). It is worth mention-
ing that in our experiments, Exo1 protein levels remain con-
stant also during an unperturbed cell cycle (Figure 1A and
Supplementary Figure S1B), although a recent study has
reported that Exo1 protein levels fluctuate along the cell cy-
cle independently of Rad53 (49). These differences might
be due to a different experimental set-up, as in their experi-
ments, -factor was re-added during S phase.
Regarding to the importance of protein interactions in
Exo1 regulation, a conserved EXO1/14-3-3 proteins in-
teraction from yeast to mammalian cells has been de-
scribed (48,88). In yeast, this interaction depends on an ac-
tive checkpoint, while human EXO1 constitutively interacts
with the 14-3-3 proteins, through a binding domain that is
not present in yeast Exo1 (89). In fact, while the nuclease
domain of EXO1 is highly conserved (90), its C-terminal re-
gion, which mediates interaction with other proteins, is not
(61). The interaction between human EXO1 and the 14-3-
3 proteins suppresses EXO1 recruitment to damaged sites
and avoid overresection by reducing its association with
PCNA (89,91–92). However, this association has not been
described in yeast and the role of the EXO1/14-3-3 proteins
interaction could be very different in yeast and human cells.
Also distinct from yeast Exo1, the C-terminus of human
EXO1 is phosphorylated by CDKs in the S/G2 phases of
the cell cycle, which regulates EXO1 recruitment to DSBs.
14-3-3 proteins can bind phosphorylated proteins (93),
and, in yeast, they have been proposed to promote fork
stability and progression by regulating the phosphorylation
status of Exo1 (48,88), although it was not known whether
14-3-3 proteins bind phosphorylated or unphosphorylated
Exo1. We have shown here that Bmh1 interacts with phos-
phorylated wild-type Exo1 protein (Figure 7B), and this in-
teraction is preserved with Exo1–23D (Figure 7C), indicat-
ing that it behaves like a functional phospho-mimic ver-
sion. Remarkably, the Exo1/Bmh1 interaction is Rad53-
dependent (Figure 7A) and it is not detected in the exo1–
23A phospho-null mutant (Figure 7C), indicating that the
binding of 14-3-3 proteins to Exo1 is phospho-dependent.
These results may be important to understand the nature
of the binding of 14-3-3 proteins to checkpoint targets like
Exo1. Our results indicated that fork stability is maintained
in rad53exo1–23D mutants in HU in the absence of func-
tional 14-3-3 proteins (Figure 7D). Therefore, the 14-3-3
proteins may help control Exo1 together with checkpoint-
dependent phosphorylation, perhaps by inducing or sup-
porting Exo1 hyper-phosphorylation, but once established
this stage, they seem dispensable to preserve fork stability.
It has been recently proposed that the 14-3-3 proteins reg-
ulate Exo1 cellular localization (94). However, this regula-
tion does not require Rad53-dependent phosphorylation.
Therefore, at the present time, the biological meaning of the
Exo1/14-3-3 interaction in the frame of the checkpoint re-
sponse to replication stress is still unclear.
A defective Exo1 regulation has a great impact in the
stability of replication forks under replicative stress lead-
ing to fork collapse and the inability to restart damaged
forks, which can result in double-strand breaks, genome
rearrangements and cell death. All these events threaten
genome stability and can let to cellular transformation. In
fact, increased levels of EXO1 are detrimental and lead to
genomic instability (95), and deregulation of EXO1 protein
levels in tumours is commonly reported (96,97). Therefore,
deciphering how the S phase checkpoint restrains Exo1 ac-
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